CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
METAFORA develops a blood-based diagnostic platform called METAdiag, which uses proprietary biomarkers to assess cellular nutrient needs. Its first test, METAglut1, aims to enable early diagnosis of GLUT1 Deficiency Syndrome in children.
METAFORA develops a disruptive blood-based In Vitro Diagnostic platform called METAdiag, METAdiag monitors cells’ energetic needs thanks to unique, proprietary biomarkers (Receptor Binding Domains or RBDs), able to quantify nutrient
transporters used by cells to feed on glucose, amino acids, vitamins and other essential nutrient transporters at the cell’s surface.Cutting edge algorithms using Artificial Intelligence to handle big data participate in generating
actionable results to physicians fo…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.